Activities, Bill Numbers and Titles
|
|
Client: GENENTECH, INC.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $3,846.15
|
Senate Bill
|
2492
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
4891
|
An Act promoting access and affordability of prescription drugs
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2499
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
4910
|
An Act promoting access and affordability of prescription drugs
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|